Back to
BALYASNY ASSET MANAGEMENT L.P.
EPRX4 quarters
Position history for
BALYASNY ASSET MANAGEMENT L.P.'s holdings in EUPRAXIA PHARMACEUTICALS INC
BALYASNY ASSET MANAGEMENT L.P. holds 1.4M shares of EPRX (EUPRAXIA PHARMACEUTICALS INC), worth $8.9M as of 2026-Q2. The position was increased. EPRX represents 0.0% of BALYASNY ASSET MANAGEMENT L.P.'s portfolio.
Current Value
$8.9M
Current Shares
1.4M
Total Value Change
+$958,599
Total Shares Change
+15
Quarter-by-Quarter History
Other major holders of EPRX: SCOTIA CAPITAL INC., Point72 Asset Management, L.P.